DE69725155D1 - Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure - Google Patents

Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure

Info

Publication number
DE69725155D1
DE69725155D1 DE69725155T DE69725155T DE69725155D1 DE 69725155 D1 DE69725155 D1 DE 69725155D1 DE 69725155 T DE69725155 T DE 69725155T DE 69725155 T DE69725155 T DE 69725155T DE 69725155 D1 DE69725155 D1 DE 69725155D1
Authority
DE
Germany
Prior art keywords
phase
isosorbide nitrate
combination
isosorbide
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69725155T
Other languages
English (en)
Inventor
Ronald Brown Miller
Thomas Leslie
Sandra Therese Antoi Malkowska
Derek Allan Prater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621749.2A external-priority patent/GB9621749D0/en
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of DE69725155D1 publication Critical patent/DE69725155D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69725155T 1996-10-18 1997-10-15 Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure Expired - Lifetime DE69725155D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9621749.2A GB9621749D0 (en) 1996-10-18 1996-10-18 Pharmaceutical combination formulation
GBGB9713549.5A GB9713549D0 (en) 1996-10-18 1997-06-26 Pharmaceutical combination formulation
PCT/GB1997/002849 WO1998017271A1 (en) 1996-10-18 1997-10-15 Pharmaceutical composition comprising a combination of isosorbide nitrate with acetylsalicylic acid

Publications (1)

Publication Number Publication Date
DE69725155D1 true DE69725155D1 (de) 2003-10-30

Family

ID=26310251

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69725155T Expired - Lifetime DE69725155D1 (de) 1996-10-18 1997-10-15 Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure

Country Status (6)

Country Link
EP (1) EP0930880B1 (de)
AT (1) ATE250414T1 (de)
AU (1) AU4633197A (de)
DE (1) DE69725155D1 (de)
GB (1) GB9713549D0 (de)
WO (1) WO1998017271A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9905261A (pt) * 1999-09-30 2001-07-24 Libbs Farmaceutica Ltda Uma nova associação medicamentosa de liberação programada
CN105902509B (zh) * 2015-09-28 2018-08-17 天方药业有限公司 一种复方单硝酸异山梨酯缓释片及其制备方法
CN110559269A (zh) * 2019-08-15 2019-12-13 仁和堂药业有限公司 一种单硝酸异山梨酯片剂及其质量检测方法
CN110478328A (zh) * 2019-08-15 2019-11-22 仁和堂药业有限公司 单硝酸异山梨酯片的制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61148115A (ja) * 1984-12-21 1986-07-05 Tooa Eiyoo Kk 難溶性薬物の徐放性製剤及びその製造法
GB2284350B (en) * 1992-07-30 1996-08-28 Cal Int Ltd Pharmaceutical compositions comprising esters of organic nitrates and a salicylate
DE69429710T2 (de) * 1993-11-23 2002-08-08 Euro Celtique Sa Verfahren zur Herstellung einer Arzneizusammensetzung mit verzögerter Wirkstoffabgabe

Also Published As

Publication number Publication date
GB9713549D0 (en) 1997-09-03
ATE250414T1 (de) 2003-10-15
EP0930880A1 (de) 1999-07-28
WO1998017271A1 (en) 1998-04-30
EP0930880B1 (de) 2003-09-24
AU4633197A (en) 1998-05-15

Similar Documents

Publication Publication Date Title
CA2307018A1 (en) Osmotic medicament releasing system
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
US7939522B1 (en) Dosage formulations for acetylcholinesterase inhibitors
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
NO890194L (no) Galenisk middel.
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
DE3778781D1 (de) Antiphlogistika enthaltende pharmazeutische formulierungen mit gesteuerter freigabe.
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
JP3018160B2 (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
KR930009605A (ko) 소염 또는 진통제
Schor et al. Susadrin transmucosal tablets (nitroglycerin in Synchron® controlled-release base)
DE69725155D1 (de) Pharmazeutische zubereitungen enthaltend eine kombination aus isosorbid-nitrat und acetylsalicylsaeure
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
CA2105541A1 (en) Programmed Release Tablets Containing Naproxen
WO2003099214A3 (en) Biguanide formulations
CA2091134A1 (en) Therapeutic agent for threatened abortion
RU93004785A (ru) Твердые капсулы окфосфата цитарабина
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
KR910007528A (ko) 벤조디아제핀 및 페닐피릴케톤 유도체의 용도
KR910004181A (ko) 생체내 유효성을 증가시키는 신규의 제약학적 경구 투여 형태
Highleyman Amprenavir (Agenerase) receives FDA approval. Food and Drug Administration
ATE257377T1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
TH41853A (th) การใช้ glp-1 หรือสารที่คล้ายคลึงในการบำบัดบริเวณหนึ่งของกล้ามเนื้อหัวใจตาย

Legal Events

Date Code Title Description
8332 No legal effect for de